Squarepoint Ops LLC Oyster Point Pharma, Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.95 - $11.68 $90,431 - $132,860	11,375 New	11,375 $127,000
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $145,456 - $299,220	-16,953 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.17 - $18.96 $31,445 - $58,624	-3,092 Reduced 15.43%	16,953 $310,000
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $233,925 - $362,213	20,045 New	20,045 $238,000
Q1 2021 May 17, 2021	SELL	$17.92 - $25.86 $316,682 - $456,997	-17,672 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.13 - $25.18 $320,393 - $444,980	17,672 New	17,672 $333,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.